Cleared Traditional

FX SPS (K213922) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
219d
Days
Class 2
Risk

K213922 is an FDA 510(k) clearance for the FX SPS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Pixee Medical (Besançon, FR). The FDA issued a Cleared decision on July 22, 2022 after a review of 219 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Pixee Medical devices

Submission Details

510(k) Number K213922 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 15, 2021
Decision Date July 22, 2022
Days to Decision 219 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
112d slower than avg
Panel avg: 107d · This submission: 219d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 799
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K213922.
EzDent-i / E2 / Prora View/ Smart M Viewer
K222145 · Ewoosoft Co., Ltd. · Aug 2022
Dolphin Imaging 12.0
K222072 · Patterson Dental Supply, Inc. · Aug 2022
Neurophet SCALE PET
K221405 · Neurophet., Inc. · Aug 2022
AI4CMR v1.0
K220624 · Ai4medimaging Medical Solutions S.A. · Jul 2022
AutoSeg
K220039 · Ai Medic, Inc. · Jul 2022
Functional MR V1.0
K221426 · Olea Medical S.A.S. · Jul 2022